The United States Preventive Services Task Force Recommendation against Prostate-Specific Antigen Screening—CounterpointCATALONA, William J.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 3, pp 395-397, issn 1055-9965, 3 p.Article

Open radical retropubic prostatectomyLOEB, Stacy; CATALONA, William J.Urologic oncology. 2007, Vol 25, Num 6, pp 494-498, issn 1078-1439, 5 p.Conference Paper

Should an isolated humeral lesion detected during prostate cancer metastatic survey be biopsied?KUNDU, Shilajit D; HAN, Misop; CATALONA, William J et al.The Journal of urology. 2004, Vol 172, Num 5, pp 1825-1826, issn 0022-5347, 2 p., 1Article

Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)LOEB, Stacy; GASHTI, Sara N; CATALONA, William J et al.Urologic oncology. 2009, Vol 27, Num 1, pp 64-66, issn 1078-1439, 3 p.Conference Paper

Deciding whom to biopsyAMLING, Christopher L; CATALONA, William J; KLEIN, Eric A et al.Urologic oncology. 2010, Vol 28, Num 5, pp 542-545, issn 1078-1439, 4 p.Conference Paper

Serial biopsy results in prostate cancer screening studyROEHL, Kimberly A; ANTENOR, Jo Ann V; CATALONA, William J et al.The Journal of urology. 2002, Vol 167, Num 6, pp 2435-2439, issn 0022-5347Article

Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. rangeROEHL, Kimberly A; ANTENOR, Jo Ann V; CATALONA, William J et al.The Journal of urology. 2002, Vol 168, Num 3, pp 922-925, issn 0022-5347Article

Number of prostate cancer risk alleles may identify possibly 'insignificant' diseaseHELFAND, Brian T; LOEB, Stacy; KAN, Donghui et al.BJU international (Papier). 2010, Vol 106, Num 11, pp 1602-1606, issn 1464-4096, 5 p.Article

Prostate Cancer Risk Alleles Significantly Improve Disease Detection and are Associated With Aggressive Features in Patients With a Normal Prostate Specific Antigen and Digital Rectal ExaminationHELFAND, Brian T; DONGHUI KAN; MODI, Parth et al.The Prostate. 2011, Vol 71, Num 4, pp 394-402, issn 0270-4137, 9 p.Article

Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsyEGGENER, Scott E; ROEHL, Kimberly A; CATALONA, William J et al.The Journal of urology. 2005, Vol 174, Num 2, pp 500-504, issn 0022-5347, 5 p.Article

Complications of Open Radical Retropubic Prostatectomy in Potential Candidates for Active MonitoringLOEB, Stacy; ROEHL, Kimberly A; HELFAND, Brian T et al.Urology (Ridgewood, NJ). 2008, Vol 72, Num 4, pp 887-891, issn 0090-4295, 5 p.Article

Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate : A preliminary analysisHUI ZHU; ROEHL, Kimberly A; ANTENOR, Jo Ann V et al.Urology (Ridgewood, NJ). 2005, Vol 66, Num 3, pp 547-551, issn 0090-4295, 5 p.Article

High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma : Current level of risk in screening populationGOKDEN, Neriman; ROEHL, Kimberly A; CATALONA, William J et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 3, pp 538-542, issn 0090-4295, 5 p.Article

Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancerLOEB, Stacy; SMITH, Norm D; ROEHL, Kimberly A et al.Urology (Ridgewood, NJ). 2007, Vol 69, Num 6, pp 1170-1175, issn 0090-4295, 6 p.Article

Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy : 10-year outcome estimatesPAZONA, Joseph F; HAN, Misop; HAWKINS, Sheila A et al.The Journal of urology. 2005, Vol 174, Num 4, pp 1282-1286, issn 0022-5347, 5 p., 1Article

External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy seriesLOEB, Stacy; CARVALHAL, Gustavo F; KAN, Donghui et al.Urologic oncology. 2012, Vol 30, Num 5, pp 584-589, issn 1078-1439, 6 p.Article

Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonographyLOEB, Stacy; HAN, Misop; ROEHL, Kimberly A et al.The Journal of urology. 2005, Vol 173, Num 1, pp 63-65, issn 0022-5347, 3 p.Article

Clinical value of longitudinal free-to-total prostate specific antigen ratio slope to diagnosis of prostate cancerHUI ZHU; ROEHL, Kimberly A; ANTENOR, Jo Ann V et al.The Journal of urology. 2004, Vol 171, Num 2, pp 661-663, issn 0022-5347, 3 p., 1Article

No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam). Commentary. Author's replyROOBOL, M. J; VAN DER CRUIJSEN, I. W; SCHRÖDER, F. H et al.Urology (Ridgewood, NJ). 2004, Vol 63, Num 5, pp 892-899, issn 0090-4295, 8 p.Article

Baseline Prostate-Specific Antigen Testing at a Young AgeLOEB, Stacy; CARTER, H. Ballentine; CATALONA, William J et al.European urology. 2012, Vol 61, Num 1, pp 1-7, issn 0302-2838, 7 p.Article

Is the utility of prostate-specific antigen velocity for prostate cancer detection affected by age?LOEB, Stacy; ROEHL, Kimberly A; CATALONA, William J et al.BJU international (Papier). 2008, Vol 101, Num 7, pp 817-821, issn 1464-4096, 5 p.Article

The association between total prostate specific antigen concentration and prostate specific antigen velocity. CommentaryXIAOYING YU; LOEB, Stacy; ROEHL, Kimberly A et al.The Journal of urology. 2007, Vol 177, Num 4, pp 1298-1302, issn 0022-5347, 5 p.Article

More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study : PSA era and threshold-specific effectsJANG, Thomas L; HAN, Misop; ROEHL, Kimberly A et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 2, pp 343-348, issn 0090-4295, 6 p.Article

Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancerLOEB, Stacy; JEFFREY METTER, E; DONGHUI KAN et al.BJU international (Papier). 2012, Vol 109, Num 4, pp 508-514, issn 1464-4096, 7 p.Article

Is statin use associated with prostate cancer aggressiveness?LOEB, Stacy; DONGHUI KAN; HELFAND, Brian T et al.BJU international (Papier). 2010, Vol 105, Num 9, pp 1222-1225, issn 1464-4096, 4 p.Article